Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1988 Jun;131(3):497–506.

Antigenic charge as a factor in resistance to immunosuppressive therapy.

S G Adler 1, H Y Wang 1, A H Cohen 1, W A Border 1
PMCID: PMC1880694  PMID: 2968049

Abstract

This study examines the effects of methylprednisolone (MP) on the glomerular lesions induced by the injection of cationic bovine serum albumin (BSA) in rabbits. Male New Zealand white rabbits (n = 55) were treated with cationic BSA alone (n = 13), cationic BSA plus MP (n = 26), native BSA alone (n = 8), or native BSA plus MP (n = 8). Animals receiving BSA alone developed subepithelial immune complex deposits after injections of cationic BSA or mesangial immune complex deposits after injections of native BSA. Subepithelial deposits were inhibited in only 10 of 26 rabbits receiving MP and cationic BSA. Glomerular lesions occurred rather predictably in this group unless complete ablation of antibody production was achieved. Even minimal amounts of detectable antibody were sufficient to support the development of the full-blown renal lesion. Proteinuria was diminished in all animals receiving cationic BSA and MP in whom a beneficial histologic effect was observed. MP inhibited the development of mesangial deposits in all of the animals given native BSA. This inhibition was associated with almost complete ablation of anti-BSA antibody production in this group. Renal perfusion studies (n = 8) demonstrated that the beneficial effects of MP on the development of immune deposits were related to systemic immunosuppression and not to local structural alterations in the glomerulus. Our findings confirm that the pattern of immune response to native and cationic antigens differ. In addition, they demonstrate that cationic antigens appear to require only small amounts of free circulating antibody in order to produce glomerular immune complexes and cause proteinuria.

Full text

PDF
497

Images in this article

500Figure 1
on p.500
501Figure 3
on p.501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S. G., Wang H., Ward H. J., Cohen A. H., Border W. A. Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. J Clin Invest. 1983 Mar;71(3):487–499. doi: 10.1172/JCI110793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agodoa L. Y., Gauthier V. J., Mannik M. Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol. 1985 Feb;134(2):880–884. [PubMed] [Google Scholar]
  3. Agodoa L. Y., Mannik M. Removal of subepithelial immune complexes with excess unaltered or cationic antigen. Kidney Int. 1987 Jul;32(1):13–18. doi: 10.1038/ki.1987.165. [DOI] [PubMed] [Google Scholar]
  4. Border W. A., Ward H. J., Kamil E. S., Cohen A. H. Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest. 1982 Feb;69(2):451–461. doi: 10.1172/JCI110469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Caulfield J. P., Farquhar M. G. Distribution of annionic sites in glomerular basement membranes: their possible role in filtration and attachment. Proc Natl Acad Sci U S A. 1976 May;73(5):1646–1650. doi: 10.1073/pnas.73.5.1646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Caulin-Glaser T., Gallo G. R., Lamm M. E. Nondissociating cationic immune complexes can deposit in glomerular basement membrane. J Exp Med. 1983 Nov 1;158(5):1561–1572. doi: 10.1084/jem.158.5.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cochrane C. G., Hawkins D. Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels. J Exp Med. 1968 Jan 1;127(1):137–154. doi: 10.1084/jem.127.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Couser W. G. Mechanisms of glomerular injury in immune-complex disease. Kidney Int. 1985 Sep;28(3):569–583. doi: 10.1038/ki.1985.167. [DOI] [PubMed] [Google Scholar]
  9. Couser W. G., Salant D. J. In situ immune complex formation and glomerular injury. Kidney Int. 1980 Jan;17(1):1–13. doi: 10.1038/ki.1980.1. [DOI] [PubMed] [Google Scholar]
  10. DIXON F. J., FELDMAN J. D., VAZQUEZ J. J. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. doi: 10.1084/jem.113.5.899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fleuren G. J., Hoedemaeker P. J. Triple-drug treatment of autologous immune complex glomerulonephritis. Clin Exp Immunol. 1980 Aug;41(2):218–224. [PMC free article] [PubMed] [Google Scholar]
  12. Ford P. M. The effect of manipulation of reticuloendothelial system activity on glomerular deposition of aggregated protein and immune complexes in two different strains of mice. Br J Exp Pathol. 1975 Dec;56(6):523–529. [PMC free article] [PubMed] [Google Scholar]
  13. Friedman A. L., Chesney R. W. Glucocorticoids in renal disease. Theoretical basis, consequences and efficacy of use in the pediatric patient. Am J Nephrol. 1982;2(6):330–341. doi: 10.1159/000166673. [DOI] [PubMed] [Google Scholar]
  14. Gallo G. R., Caulin-Glaser T., Lamm M. E. Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest. 1981 May;67(5):1305–1313. doi: 10.1172/JCI110159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Garattini S., Bertani T., Remuzzi G. What is the basis for the use of steroids in the treatment of idiopathic membranous nephropathy? Nephron. 1987;45(1):1–6. doi: 10.1159/000184062. [DOI] [PubMed] [Google Scholar]
  16. Gauthier V. J., Mannik M. Only the initial binding of cationic immune complexes to glomerular anionic sites is mediated by charge-charge interactions. J Immunol. 1986 May 1;136(9):3266–3271. [PubMed] [Google Scholar]
  17. Gauthier V. J., Mannik M., Striker G. E. Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med. 1982 Sep 1;156(3):766–777. doi: 10.1084/jem.156.3.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Germuth F. G., Jr, Rodriguez E., Lorelle C. A., Trump E. I., Milano L. L., Wise O. Passive immune complex glomerulonephritis in mice: models for various lesions found in human disease. II. Low avidity complexes and diffuse proliferative glomerulonephritis with subepithelial deposits. Lab Invest. 1979 Oct;41(4):366–371. [PubMed] [Google Scholar]
  19. Germuth F. G., Jr, Senterfit L. B., Pollack A. D. Immune complex disease. I. Experimental acute and chronic glomerulonephritis. Johns Hopkins Med J. 1967 Apr;120(4):225–251. [PubMed] [Google Scholar]
  20. Germuth F. G., Jr, Valdes A. J., Senterfit L. B., Pollack A. D. A unique influence of cortisone on the transit of specific macromolecules across vascular walls in immune complex disease. Johns Hopkins Med J. 1968 Mar;122(3):137–153. [PubMed] [Google Scholar]
  21. Hahn B. H., Knotts L., Ng M., Hamilton T. R. Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice. Arthritis Rheum. 1975 Mar-Apr;18(2):145–152. doi: 10.1002/art.1780180212. [DOI] [PubMed] [Google Scholar]
  22. Hebert L. A., Allhiser C. L., Koethe S. M. Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int. 1978 Nov;14(5):452–465. doi: 10.1038/ki.1978.150. [DOI] [PubMed] [Google Scholar]
  23. Hoffsten P. E., Swerdlin A., Bartell M., Hill C. L., Venverloh J., Brotherson K., Klahr S. Reticuloendothelial and mesangial function in murine immune complex glomerulonephritis. Kidney Int. 1979 Feb;15(2):144–159. doi: 10.1038/ki.1979.20. [DOI] [PubMed] [Google Scholar]
  24. Holdsworth S. R., Bellomo R. Differential effects of steroids on leukocyte-mediated glomerulonephritis in the rabbit. Kidney Int. 1984 Aug;26(2):162–169. doi: 10.1038/ki.1984.150. [DOI] [PubMed] [Google Scholar]
  25. Kanwar Y. S., Farquhar M. G. Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol. 1979 Apr;81(1):137–153. doi: 10.1083/jcb.81.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kniker W. T., Cochrane C. G. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med. 1968 Jan 1;127(1):119–136. doi: 10.1084/jem.127.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lim V. S., Spargo B. Immunosuppressive treatment of autologous immune complex nephritis in rats. J Lab Clin Med. 1973 May;81(5):661–670. [PubMed] [Google Scholar]
  28. Madaio M. P., Salant D. J., Adler S., Darby C., Couser W. G. Effect of antibody charge and concentration on deposition of antibody to glomerular basement membrane. Kidney Int. 1984 Oct;26(4):397–403. doi: 10.1038/ki.1984.188. [DOI] [PubMed] [Google Scholar]
  29. Muckerheide A., Apple R. J., Pesce A. J., Michael J. G. Cationization of protein antigens. I. Alteration of immunogenic properties. J Immunol. 1987 Feb 1;138(3):833–837. [PubMed] [Google Scholar]
  30. Oite T., Batsford S. R., Mihatsch M. J., Takamiya H., Vogt A. Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen. J Exp Med. 1982 Feb 1;155(2):460–474. doi: 10.1084/jem.155.2.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schrieber L., Mullins W. W., Jr, Plotz P. H. Failure of methotrexate and methylprednisolone to alter the clearance of model immune complexes. J Rheumatol. 1985 Dec;12(6):1044–1047. [PubMed] [Google Scholar]
  32. Tipping P. G., Holdsworth S. R. The mechanism of action of corticosteroids on glomerular injury in acute serum sickness in rabbits. Clin Exp Immunol. 1985 Mar;59(3):555–563. [PMC free article] [PubMed] [Google Scholar]
  33. Vogt A., Rohrbach R., Shimizu F., Takamiya H., Batsford S. Interaction of cationized antigen with rat glomerular basement membrane: in situ immune complex formation. Kidney Int. 1982 Jul;22(1):27–35. doi: 10.1038/ki.1982.128. [DOI] [PubMed] [Google Scholar]
  34. Wilson C. B., Dixon F. J. Quantitation of acute and chronic serum sickness in the rabbit. J Exp Med. 1971 Sep 1;134(3 Pt 2):7s–8s. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES